Single dose of DMT shows promise for treatment-resistant depression in early clinical trial

BY THE OPTIMIST DAILY EDITORIAL TEAM A single, carefully administered dose of the psychedelic compound dimethyltryptamine, better known as DMT, may offer meaningful relief for people living with treatment-resistant depression, according to results from a new clinical trial. In the small study, published in Nature Medicine, researchers found that when DMT was combined with structured […] The post Single dose of DMT shows promise for treatment-resistant depression in early clinical trial first appeared on The Optimist Daily: Making Solutions the News.